Intermittent Hypoxia + Upper Limb Training for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help individuals with spinal cord injuries improve arm and hand function. It combines a breathing technique called Acute Intermittent Hypoxia (AIH), which involves short bursts of low oxygen, with upper limb training using the Armeo Spring device to enhance dexterity and daily living activities. Participants will be divided into groups to test AIH alone, AIH with training, sham (fake) AIH with training, or sham AIH alone. Suitable candidates have had a stable spinal cord injury for at least six months and can move their hands slightly or use a wrist extension grip. As an Early Phase 1 trial, this research focuses on understanding how the treatment works in people, offering participants a chance to be among the first to receive this innovative approach.
Will I have to stop taking my current medications?
Participants do not have to stop taking antispasticity medications to join the study. The protocol does not specify about other medications, so it's best to discuss with the study team.
What prior data suggests that this protocol is safe for improving upper extremity function in spinal cord injury?
Previous studies have shown that Acute Intermittent Hypoxia (AIH) is generally safe and effective for individuals with spinal cord injuries. AIH involves short periods of breathing air with reduced oxygen, which can improve movement abilities. Research indicates that AIH can enhance hand use and walking in these individuals. Importantly, studies on AIH for conditions like stroke and multiple sclerosis also support its safety.
When combined with arm exercises, AIH has shown promise in improving hand strength and skill. One study found that a single AIH session can boost grip and pinch strength, with the best effects appearing a few hours after treatment. While these results are promising, they come from early research stages focused on assessing safety and tolerance. This means the treatment has passed initial safety tests but requires further study to fully confirm its safety.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for spinal cord injury because they explore the potential of combining intermittent hypoxia with upper limb robotic training. Unlike current treatment options, which often focus on physical therapy alone, this approach uses short bursts of low oxygen (intermittent hypoxia) to potentially stimulate nerve regeneration and enhance recovery. The Armeo Spring robotic device provides targeted, repetitive arm movements, which are crucial for rehabilitation. By combining these two methods, the treatments aim to maximize the recovery of arm function, offering a promising new direction for improving outcomes in spinal cord injury patients.
What evidence suggests that this trial's treatments could be effective for improving upper extremity function in spinal cord injury?
Research has shown that Acute Intermittent Hypoxia (AIH), a treatment in this trial, can improve movement in people with spinal cord injuries. Studies have found that a single AIH session can enhance grip and pinch strength, with optimal results appearing about 3 hours afterward. AIH temporarily reduces oxygen levels, which appears to activate the spinal cord and strengthen nerve connections. In this trial, some participants will receive AIH combined with upper extremity training, potentially boosting recovery further. This combination has shown promise in improving muscle strength and movement for people with spinal cord injuries.12367
Are You a Good Fit for This Trial?
This trial is for individuals with non-progressive spinal cord injuries at levels C1-T1, who have some hand muscle activation or can use a tenodesis grasp. They must be over 6 months post-injury, not severely anemic (hemoglobin ≥10g/dl), and have stable blood pressure. It's not suitable for those with certain medical conditions like uncontrolled hypertension or diabetes, severe respiratory issues, heart problems, pregnant women, or those on mechanical ventilation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Acute Intermittent Hypoxia (AIH) in combination with upper extremity training to evaluate changes in upper extremity function, dexterity, and ability to complete activities of daily living
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Acute Intermittent Hypoxia
- Upper extremity training/Armeo Spring
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor